Celia C Chang

Array ( [id] => 4814002 [patent_doc_number] => 20080194633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Certain chemical entities, compositions, and methods' [patent_app_type] => utility [patent_app_number] => 11/888892 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31045 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194633.pdf [firstpage_image] =>[orig_patent_app_number] => 11888892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765727 [patent_doc_number] => 20080176939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/832540 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51077 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176939.pdf [firstpage_image] =>[orig_patent_app_number] => 11832540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4834001 [patent_doc_number] => 20080132548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Certain chemical entities, compositions, and methods' [patent_app_type] => utility [patent_app_number] => 11/888903 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16111 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132548.pdf [firstpage_image] =>[orig_patent_app_number] => 11888903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11171187 [patent_doc_number] => 09403770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Process for preparing fexofenadine' [patent_app_type] => utility [patent_app_number] => 12/374539 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1351 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12374539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046776 [patent_doc_number] => 20070265450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'NOVEL PROCESSES FOR THE PREPARATION OF (R)-ALPHA-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL' [patent_app_type] => utility [patent_app_number] => 11/782902 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65550 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265450.pdf [firstpage_image] =>[orig_patent_app_number] => 11782902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840447 [patent_doc_number] => 20080280933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'BENZIMIDAZOLYL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/780579 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47386 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280933.pdf [firstpage_image] =>[orig_patent_app_number] => 11780579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231411 [patent_doc_number] => 20070293519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Analogs of thalidomide as potential angiogenesis inhibitors' [patent_app_type] => utility [patent_app_number] => 11/880404 [patent_app_country] => US [patent_app_date] => 2007-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7340 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293519.pdf [firstpage_image] =>[orig_patent_app_number] => 11880404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534791 [patent_doc_number] => 09260411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile' [patent_app_type] => utility [patent_app_number] => 11/779936 [patent_app_country] => US [patent_app_date] => 2007-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17803 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11779936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693150 [patent_doc_number] => 20080085921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Stereoisomeric Compounds And Methods For The Treatment Of Gastrointestinal And Central Nervous System Disorders' [patent_app_type] => utility [patent_app_number] => 11/778315 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18138 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085921.pdf [firstpage_image] =>[orig_patent_app_number] => 11778315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724367 [patent_doc_number] => 08097638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Pyridines for treating injured mammalian nerve tissue' [patent_app_type] => utility [patent_app_number] => 11/778524 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14007 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097638.pdf [firstpage_image] =>[orig_patent_app_number] => 11778524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779498 [patent_doc_number] => 20080287496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => '1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels' [patent_app_type] => utility [patent_app_number] => 11/827802 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6065 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287496.pdf [firstpage_image] =>[orig_patent_app_number] => 11827802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016703 [patent_doc_number] => 20070259912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Polymorphic forms of a GABAA agonist' [patent_app_type] => utility [patent_app_number] => 11/827570 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4321 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259912.pdf [firstpage_image] =>[orig_patent_app_number] => 11827570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304226 [patent_doc_number] => 20090298878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'OXIME COMPOUNDS AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/373328 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 217653 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298878.pdf [firstpage_image] =>[orig_patent_app_number] => 12373328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823318 [patent_doc_number] => 20080227799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'CXCR4 Antagonists Including Heteroatoms for the Treatment of Medical Disorders' [patent_app_type] => utility [patent_app_number] => 11/776465 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22044 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227799.pdf [firstpage_image] =>[orig_patent_app_number] => 11776465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688830 [patent_doc_number] => 20080033011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'NOVEL BENZO[D][1,3]-DIOXOL DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/775857 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19719 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033011.pdf [firstpage_image] =>[orig_patent_app_number] => 11775857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797937 [patent_doc_number] => 20080009523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'New Pyridine Analogues IV' [patent_app_type] => utility [patent_app_number] => 11/772257 [patent_app_country] => US [patent_app_date] => 2007-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20225 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009523.pdf [firstpage_image] =>[orig_patent_app_number] => 11772257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374807 [patent_doc_number] => 20090312368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Pyridine Analogues IV' [patent_app_type] => utility [patent_app_number] => 12/307284 [patent_app_country] => US [patent_app_date] => 2007-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20133 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312368.pdf [firstpage_image] =>[orig_patent_app_number] => 12307284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652181 [patent_doc_number] => 20080039437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'New Pyridine Analogues III' [patent_app_type] => utility [patent_app_number] => 11/772269 [patent_app_country] => US [patent_app_date] => 2007-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56576 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039437.pdf [firstpage_image] =>[orig_patent_app_number] => 11772269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4933538 [patent_doc_number] => 20080004313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Preparation of crystalline polymorphs of rimonabant hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/818986 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13272 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004313.pdf [firstpage_image] =>[orig_patent_app_number] => 11818986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199753 [patent_doc_number] => 20070299071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Substituted phenyl methanone derivatives' [patent_app_type] => utility [patent_app_number] => 11/818676 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8528 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299071.pdf [firstpage_image] =>[orig_patent_app_number] => 11818676 [rel_patent_id] =>[rel_patent_doc_number] =>)